Kisacik, B. Et Al. 2014. Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.. ARTHRITIS & RHEUMATOLOGY , vol.66 .

Kisacik, B., Pamuk, O., Onat, A. M., Erer, B., Hatemi, G., Ozguler, Y., ... Pehlivan, Y.(2014). Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.. ARTHRITIS & RHEUMATOLOGY , vol.66.

Kisacik, Bunyamin Et Al. "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.," ARTHRITIS & RHEUMATOLOGY , vol.66, 2014

Kisacik, Bunyamin Et Al. "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.." ARTHRITIS & RHEUMATOLOGY , vol.66, 2014

Kisacik, B. Et Al. (2014) . "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.." ARTHRITIS & RHEUMATOLOGY , vol.66.

@article{article, author={Bunyamin Kisacik Et Al. }, title={Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2014}